86 results
Page 3 of 5
8-K
EX-99.1
ujj6ji1tg8umfrdwhe
30 Mar 22
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results
4:05pm
8-K
EX-99.1
kobmp9ad8r4je5lkp
1 Mar 22
Crinetics Pharmaceuticals Expands Executive Team with Appointment of James Hassard as Chief Commercial Officer
8:00am
8-K
f28ok8eyawv q27
1 Mar 22
Crinetics Pharmaceuticals Expands Executive Team with Appointment of James Hassard as Chief Commercial Officer
8:00am
8-K
EX-99.1
rjxn8og
5 Jan 22
Departure of Directors or Certain Officers
5:00pm
424B5
p6il7w8b
21 Oct 21
Prospectus supplement for primary offering
4:26pm
8-K
EX-1.1
64qvwl
21 Oct 21
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:24pm
424B5
q9y0qz44hgjm4px 7aq
20 Oct 21
Prospectus supplement for primary offering
4:15pm
S-3ASR
hb3ucfp8
10 Aug 21
Automatic shelf registration
5:25pm
8-K
EX-99.1
zb4oatnaqwoouw3wa7
29 Jul 21
Stock Purchase Agreement
4:15pm
DEFA14A
abooe07c35 ubz
30 Apr 21
Additional proxy soliciting materials
12:00am
8-K
EX-1.1
dae9g92dy6dbj
8 Apr 21
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4:09pm
424B5
zip8 xxc7zi9ej2cz4s
8 Apr 21
Prospectus supplement for primary offering
4:07pm
8-K
EX-99.1
m5k6kegcf8of1y
30 Mar 21
Crinetics Pharmaceuticals Announces 2021 Clinical Plans and Reports Fourth Quarter and Full Year 2020 Financial Results
5:05pm